Stock analysis for Natera Inc (NTRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Natera Inc. Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services.
Natera Inc (NTRA:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health.
Natera Inc. NTRA shares rose slightly in premarket trading after a Delaware court awarded the company a 30% ongoing royalty on post-injunction revenues tied to its MRD-related patents. The April 6, ...
Natera Inc. NTRA shares are up on Tuesday as the company announced promising results from a prospective study regarding its Signatera molecular residual disease (MRD) test. Natera stock is showing ...
AUSTIN, TX—Sheena Jonathan, co-founder and director of Natera, Inc. (NASDAQ:NTRA), a company whose stock has surged over 158% in the past year and currently commands a market capitalization of $22.7 ...
– STELLAR-316 will use Natera’s Signatera™ assay to identify MRD-positive patients for trial enrollment and to monitor response to therapy – Using Natera’s Signatera™ test following completion of ...
Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making.
A detailed overview of Natera, Inc. (NTRA) stock, including real-time price, chart, key statistics, news, and more.